Details for Patent: 11,291,793
✉ Email this page to a colleague
Summary for Patent: 11,291,793
| Title: | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| Abstract: | Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. |
| Inventor(s): | David P. Rounbehler, David H. Fine |
| Assignee: | Vero Biotech Inc |
| Application Number: | US17/459,052 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Device; |
Drugs Protected by US Patent 11,291,793
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,291,793
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2005277397 | ⤷ Start Trial | |||
| Canada | 2576957 | ⤷ Start Trial | |||
| European Patent Office | 1789119 | ⤷ Start Trial | |||
| European Patent Office | 2724742 | ⤷ Start Trial | |||
| Japan | 2008510675 | ⤷ Start Trial | |||
| Japan | 2012179365 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
